Compound bovine fetal liver extract tablets
Function and Efficacy
This product, through the action of cytokines such as IGF1, FGF and inositol, induces the polysaccharide protein receptors of liver cell membranes and mitochondrial membranes, increases the activity of ATP synthase, promotes the uptake and utilization of glucose by cells, and increases energy synthesis. This product can promote the combination of fatty acids and apolipoproteins and their entry into the blood, reduce fat accumulation in the liver, promote fatty acid β-oxidation, and accelerate fat decomposition.
Ingredients
This product is a compound preparation, whose ingredients are bovine fetal liver extract (containing a variety of liver-derived peptide cytokines such as IGF1, FGF, TGFS, HGF), vitamin B12, and inositol.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Vitamin B12Ingredients |
This product, through the action of cytokines such as IGF1, FGF and inositol, induces the polysaccharide protein receptors of liver cell membranes and mitochondrial membranes, increases the activity of ATP synthase, promotes the uptake and utilization of glucose by cells, and increases energy synthesis. This product can promote the combination of fatty acids and apolipoproteins and their entry into the blood, reduce fat accumulation in the liver, promote fatty acid β-oxidation, and accelerate fat decomposition. More |
68-19-9 | 16 | |
| InositolIngredients |
It participates in inducing the glycoprotein receptors on the liver cell membrane and mitochondrial membrane, promoting the uptake and utilization of glucose by cells and increasing energy synthesis. More |
87-89-8 | 8 |
Appearance
This product is a film-coated tablet. After removing the film coating, it is light brown.
Indication
Used as an auxiliary treatment for acute and chronic hepatitis, liver fibrosis, fatty liver, cirrhosis, etc.
Usage and Dosage
Oral administration: 1-2 tablets at a time, 3 times a day, 15-30 days as a course of treatment.
Adverse Reactions
No adverse reactions have been found.
Precautions
1. It is contraindicated for patients with acute hepatic atrophy or hepatic coma. 2. It is contraindicated for patients who are allergic to this product.
Special Population Medication
Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: This experiment has not been conducted and there is no reliable reference. Precautions for the elderly: This experiment has not been conducted and there is no reliable reference.
Drug Interactions
This experiment has not been conducted and there are no reliable references.
Storage
Keep away from light and store in sealed container.
Packaging Specification
40 mg (peptide)
Validity Period
Tentative 24 months
Manufacturer
Shandong Xili Pharmaceutical Co., Ltd.
-
Founded in:
2000-12-29 -
Address:
Room 201, 2nd Floor, Xili Office Building, No. 2526, Huanghe East Road, Danyang Street, Luxi New District, Heze City, Shandong Province -
Tax NO.:
9137170016885208XA -
Registered Funds:
30 million yuan -
Website:
-
Email: